Advance Search
Volume 38 Issue 3
Feb.  2022
Turn off MathJax
Article Contents
JIANG Wei, MAO Xian-hua, LIU Zhen-qiu, . Changing trend in reported hepatitis B incidence among residents of mainland China, 2004 – 2017[J]. Chinese Journal of Public Health, 2022, 38(3): 257-261. doi: 10.11847/zgggws1132715
Citation: JIANG Wei, MAO Xian-hua, LIU Zhen-qiu, . Changing trend in reported hepatitis B incidence among residents of mainland China, 2004 – 2017[J]. Chinese Journal of Public Health, 2022, 38(3): 257-261. doi: 10.11847/zgggws1132715

Changing trend in reported hepatitis B incidence among residents of mainland China, 2004 – 2017

doi: 10.11847/zgggws1132715
  • Received Date: 2020-10-10
    Available Online: 2021-11-16
  • Publish Date: 2022-03-10
  •   Objective  To analyze the trend of reported incidence of hepatitis B (HB) in mainland China from 2004 to 2017 to provide evidences for developing strategies on HB prevention and control.   Methods  From National Public Health Science Data Center, we extracted the data on HB incidence in 31 provincial-level administrative divisions (not including Chinese Taiwan, Hong Kong Special Administrative Region and Macao Special Administrative Region) reported from March 2004 through March 2017. The average annual percentage change (AAPC) in region-, gender- and age group-specific HB incidence were calculated to assess variation trend of HB incidence during the period.   Results  From 2004 to 2017, the average reported incidence (per 100 000 population) of HB for the 31 divisions were 70.50, 75.57, 84.82, 89.00, 88.52, 88.82, 79.46, 81.54, 80.68, 71.12, 69.05, 68.57, 68.74 and 72.61, with no significant variation in the reported incidence as a whole (AAPC = 0.2%, P > 0.05); while, the increased HB incidences were reported in 9 of the divisions, with the APPCs of 5.80% for Shanxi, 4.20% for Anhui, 1.50% for Jiangxi, 1.70% for Hubei, 11.30% for Hunan, 6.70% for Guangdong, 3.50% for Guangxi Zhuang Autonomous Region, 3.10% for Hainan, 14.50% for Tibet Autonomous Region, and 4.40% for Xinjiang Production and Construction Corps, respectively (all P < 0.05). The mean reported annual HB incidence (per 100 000 population) during the period was 97.03 for males and 57.38 for females and there was no significant variation in the incidence for both the males (AAPC = – 0.1%) and the females (AAPC = 0.5%) (both P > 0.05). The age group-specific HB incidences (per 100 000 population) were 12.78, 17.64, 80.21, 211.00, 181.62 and 163.11 for the population aged 0 – 4, 5 – 9, 10 – 19, 20 – 39, 40 – 59, and 60 years and above, respectively; the age group-specific HB incidence decreased for the groups less than 20 years (AAPC = – 7.7%, – 13.6%, and – 11.6% for groups of 0 – 4, 5 – 9, 10 – 19 years, all P < 0.001) but increased for the age groups 60 years old and above (AAPC = 5.0%, P < 0.001).   Conclusion  During 2004 – 2017 in mainland China, the reported incidence of hepatitis B was not significantly changed generally but the incidence showed an increasing trend in some regions and the residents aged 60 years and above is the key population for hepatitis B prevention.
  • loading
  • [1]
    Schweitzer A, Horn J, Mikolajczyk RT, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013[J]. The Lancet, 2015, 386(10003): 1546 – 1555. doi: 10.1016/S0140-6736(15)61412-X
    [2]
    GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980 – 2016: a systematic analysis for the Global Burden of Disease Study 2016[J]. The Lancet, 2017, 390(10100): 1151 – 1210. doi: 10.1016/S0140-6736(17)32152-9
    [3]
    Wang ZF, Chen YP, Pan JR. Trends of acute hepatitis B notifi-cation rates in eastern China from 2005 to 2013[J]. PLoS One, 2014, 9(12): e114645. doi: 10.1371/journal.pone.0114645
    [4]
    Tao J, Zhang WM, Yue HK, et al. Prevalence of hepatitis B virus infection in Shenzhen, China, 2015 – 2018[J]. Scientific Reports, 2019, 9(1): 13948. doi: 10.1038/s41598-019-50173-5
    [5]
    桑祎莹, 易静, 汪洋. 中国城乡2003 — 2017年糖尿病死亡趋势的JoinPoint回归分析[J]. 中国预防医学杂志, 2020, 21(7): 744 – 748.
    [6]
    Coffin CS, Zhou KL, Terrault NA. New and old biomarkers for diagnosis and management of chronic hepatitis B virus infection[J]. Gastroenterology, 2019, 156(2): 355 – 368.e3. doi: 10.1053/j.gastro.2018.11.037
    [7]
    Wang H, Men PX, Xiao YF, et al. Hepatitis B infection in the general population of China: a systematic review and meta-analysis[J]. BMC Infectious Diseases, 2019, 19(1): 811. doi: 10.1186/s12879-019-4428-y
    [8]
    Pereira VRZB, Wolf JM, da Silva Luz CA, et al. Risk factors for hepatitis B transmission in South Brazil[J]. Memórias do Instituto Oswaldo Cruz, 2017, 112(8): 544 – 550.
    [9]
    Gheorghe L, Csiki IE, Iacob S, et al. The prevalence and risk factors of hepatitis B virus infection in an adult population in Romania: a nationwide survey[J]. European Journal of Gastroen-terology and Hepatology, 2013, 25(1): 56 – 64. doi: 10.1097/MEG.0b013e328358b0bb
    [10]
    马岩, 方益荣, 王吉玲, 等. 2008 — 2018年绍兴市乙型病毒性肝炎流行趋势分析[J]. 预防医学, 2020, 32(1): 1 – 3, 8.
    [11]
    Cui FQ, Shen LP, Li L, et al. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China[J]. Emerging Infectious Diseases, 2017, 23(5): 765 – 772. doi: 10.3201/eid2305.161477
    [12]
    周羚, 马福宝, 汤奋扬, 等. 乙肝疫苗免疫规划对乙肝流行影响[J]. 中国公共卫生, 2010, 26(4): 444 – 446. doi: 10.11847/zgggws2010-26-04-32
    [13]
    Liu J, Yang HI, Lee MH, et al. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study[J]. Gastroenterology, 2010, 139(2): 474 – 482. doi: 10.1053/j.gastro.2010.04.048
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(3)

    Article views (66) PDF downloads(8) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return